Seeking an experienced M&A attorney in Boston? Our firm handles complex mergers, acquisitions, divestitures, and strategic transactions for companies across Biotech, Healthcare, Technology, from middle-market deals to large corporate transactions.
Our managing partner provides selective mergers & acquisitions law counsel to clients in Boston and nationwide, including:
We engage selectively with capitalized founders and investors in Boston and nationwide:
Boston is the global epicenter of biotech and life sciences M&A, with Kendall Square and the Route 128 corridor housing the densest concentration of biotech companies outside San Francisco. Beyond life sciences, the region drives significant deal activity in financial technology, education technology, and defense contracting. The region's deep research university ecosystem (MIT, Harvard, Tufts) produces a steady stream of spinoff companies ripe for acquisition.
Boston's biotech-heavy deal market means acquirers often face complex IP due diligence involving university licenses, clinical trial data, and FDA regulatory considerations. Competition from large pharma strategic acquirers can push valuations higher for promising targets.
Boston's concentration of world-class research institutions and highly educated workforce creates a self-reinforcing ecosystem where acquired companies can access talent, partnerships, and capital unavailable in other markets.
Massachusetts enacted the Noncompetition Agreement Act in 2018, limiting non-competes to 12 months and requiring garden leave pay - buyers must evaluate existing employee agreements during due diligence as many pre-2018 agreements may now be unenforceable.
We specialize in biotech and life sciences securities transactions, understanding the unique regulatory and scientific complexities of this sector.
A structured, methodical approach to mergers & acquisitions law
We work with you to define deal objectives, identify targets or buyers, and develop an M&A strategy aligned with your business goals.
Our team conducts comprehensive legal, financial, and operational due diligence to identify risks and opportunities.
We structure the transaction for optimal tax treatment, risk allocation, and regulatory compliance, whether as a stock purchase, asset purchase, or merger.
We negotiate letters of intent, purchase agreements, and all transaction documents to protect your interests and facilitate a smooth closing.
We manage the closing process and provide post-closing support for integration, earnout disputes, and transition matters.
Submit your transaction details for a preliminary assessment by our managing partner.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Common questions from Boston clients
Submit your transaction details for a preliminary assessment by our managing partner
Submit Transaction DetailsIn-depth guides to help you prepare for your transaction
Key considerations for sellers navigating the M&A process with legal representation.
Read guideA structured approach to legal, financial, and operational due diligence.
Read guideUnderstanding the binding and non-binding elements of each document.
Read guideCommon deal-killers and how experienced counsel helps prevent them.
Read guideWhat buyers should look for in a Franchise Disclosure Document.
Read guideOur managing partner provides selective mergers & acquisitions law counsel for transactions nationwide. Submit your transaction details for a preliminary assessment.
Submit transaction details for review. We engage selectively with capitalized buyers and sellers.
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Selective M&A practice - Nationwide reach - Managing partner on every deal